Obesity and type 2 diabetes

被引：17

作者：

Toplak, Hermann ^{[1
]}

Hoppichler, Friedrich ^{[2
]}

Wascher, Thomas C. ^{[5
]}

Schindler, Karin ^{[3
]}

Ludvik, Bernhard ^{[4
]}

机构：

[1] Med Univ Graz, Univ Klin Innere Med, Graz, Austria

[2] Krankenhaus Barmherzigen Bruder, Innere Med Abt, Salzburg, Austria

[3] Med Univ Wien, Klin Abt Innere Med 3, Vienna, Austria

[4] Krankenanstalt Rudolfstiftung Stadt Wien, Innere Med Abt, Vienna, Austria

[5] Hanuschkrankenhaus, Med Abt 1, Vienna, Austria

来源：

WIENER KLINISCHE WOCHENSCHRIFT | 2016年 / 128卷

关键词：

Obesity; Typ; 2; diabetes; EASO POSITION STATEMENT; WEIGHT-LOSS; LOW-CARBOHYDRATE; RISK; MANAGEMENT; OVERWEIGHT; STRENGTH; DIETS; MASS;

D O I：

10.1007/s00508-016-0986-9

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Obesity and Type 2 Diabetes are nowadays summarized as "diabesity". That is due to the fact that obesity is frequently preceding and the most important risk factor in the increase of Type 2 Diabetes. The body mass index (BMI) is a crude measure of body fatness. Even normal weight persons can have lack in muscles (sarcopenia), which leads to the recommendation to measure waist und body fatness (e.g. BIA). Lifestyle management including nutrition and physical activity are important for diabetes prevention. In the therapy of Type 2 Diabetes body weight is increasingly used as secondary target. Also the choice of the anti-diabetic medication and concomitant medications is increasingly influenced by body weight. The significance of anti-obesity medications in the therapy of type 2 diabetes will have to be clarified by future studies. Bariatric surgery is at present indicated with a BMI above BMI > 35 kg/m(2) and can lead at least to partial diabetes remission but has to be part of a lifelong care concept.

引用

页码：S196 / S200

页数：5

共 33 条

[11] Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity [J].